OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 67 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q4 2013. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,875,000 | +9275.0% | 98,700 | +6480.0% | 0.00% | – |
| Q4 2018 | $20,000 | -96.6% | 1,500 | -97.1% | 0.00% | – |
| Q3 2018 | $580,000 | -41.6% | 52,280 | -74.2% | 0.00% | -100.0% |
| Q4 2016 | $993,000 | +178.9% | 202,699 | +181.3% | 0.00% | – |
| Q3 2016 | $356,000 | -50.8% | 72,064 | -49.5% | 0.00% | -100.0% |
| Q2 2016 | $724,000 | +583.0% | 142,585 | +656.1% | 0.00% | – |
| Q1 2016 | $106,000 | -77.5% | 18,859 | -58.8% | 0.00% | – |
| Q4 2015 | $472,000 | +133.7% | 45,723 | +317.0% | 0.00% | – |
| Q3 2015 | $202,000 | -56.4% | 10,964 | -54.1% | 0.00% | – |
| Q2 2015 | $463,000 | +221.5% | 23,876 | +186.4% | 0.00% | – |
| Q1 2015 | $144,000 | +21.0% | 8,338 | +11.1% | 0.00% | – |
| Q4 2014 | $119,000 | -18.5% | 7,506 | -35.6% | 0.00% | – |
| Q3 2014 | $146,000 | +40.4% | 11,663 | +74.3% | 0.00% | – |
| Q2 2014 | $104,000 | -45.0% | 6,690 | -53.8% | 0.00% | – |
| Q1 2014 | $189,000 | -4.5% | 14,469 | +17.3% | 0.00% | – |
| Q4 2013 | $198,000 | -53.2% | 12,340 | -51.6% | 0.00% | – |
| Q3 2013 | $423,000 | – | 25,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|